Comparison of hydroxyethyl starch regulatory summaries from the Food and Drug Administration and the European Medicines Agency

This article aims to highlight the positions of the Food and Drug Administration and the European Medicines Agency regarding use and marketing of hydroxyethyl starch (HES) products, and how these have changed over recent years. In 2013, warnings from both agencies advised against use of HES in criti...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiedermann, Christian J., Eisendle, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Policy Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359805/
https://www.ncbi.nlm.nih.gov/pubmed/28331624
http://dx.doi.org/10.1186/s40545-016-0090-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359805/
https://www.ncbi.nlm.nih.gov/pubmed/28331624
http://dx.doi.org/10.1186/s40545-016-0090-6

Ejemplares similares